Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724021 | SCV000224315 | uncertain significance | not provided | 2014-07-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000724021 | SCV000714231 | benign | not provided | 2018-12-17 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000625422 | SCV000745321 | benign | Brittle cornea syndrome 1 | 2017-06-28 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002277328 | SCV002565347 | likely benign | Ehlers-Danlos syndrome | 2022-06-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002336417 | SCV002637019 | likely benign | Cardiovascular phenotype | 2019-11-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000724021 | SCV003253894 | benign | not provided | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000625422 | SCV000745861 | likely benign | Brittle cornea syndrome 1 | 2016-01-15 | no assertion criteria provided | clinical testing |